Insider Transactions in Q1 2022 at Amedisys Inc (AMED)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 29
2022
|
David L Kemmerly Officer |
SELL
Open market or private sale
|
Direct |
2,500
-4.52%
|
$440,000
$176.75 P/Share
|
Feb 20
2022
|
Christopher Gerard President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-4.7%
|
$291,447
$141.07 P/Share
|
Feb 20
2022
|
Scott G Ginn EVP, CFO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,975
-6.5%
|
$278,475
$141.07 P/Share
|
Feb 20
2022
|
David L Kemmerly Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,161
-5.81%
|
$163,701
$141.07 P/Share
|
Feb 20
2022
|
Sharon Brunecz Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,162
-4.29%
|
$163,842
$141.07 P/Share
|
Feb 20
2022
|
Michael Paul North Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,156
-11.18%
|
$162,996
$141.07 P/Share
|
Feb 20
2022
|
Denise M. Bohnert Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-2.72%
|
$50,760
$141.07 P/Share
|
Feb 17
2022
|
Paul B. K. Kusserow Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,318
-2.45%
|
$2,762,474
$143.25 P/Share
|
Feb 17
2022
|
Paul B. K. Kusserow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
49,092
+10.96%
|
-
|
Feb 17
2022
|
Christopher Gerard President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
6,109
+12.2%
|
-
|
Feb 17
2022
|
Scott G Ginn EVP, CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
2,618
+7.93%
|
-
|
Feb 17
2022
|
David L Kemmerly Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+6.14%
|
-
|
Feb 17
2022
|
Sharon Brunecz Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+4.61%
|
-
|
Feb 17
2022
|
Michael Paul North Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,309
+11.24%
|
-
|
Feb 17
2022
|
Denise M. Bohnert Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
873
+6.19%
|
-
|
Jan 06
2022
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,330
+4.72%
|
-
|
Jan 02
2022
|
Paul B. K. Kusserow Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,866
-1.44%
|
$783,426
$161.88 P/Share
|